Showing results (461-470 of 2,789) with videos related to
Sort By:
Pageof 279
Drugs & Aging|December 3, 2025
Cross-Sectional and Longitudinal Analyses of the Association Between Statin Use and Age-Related Hearing LossLizmarie G Maldonado, Lois J Matthews, Katharine A Fernandez, et al.Drugs & Aging|September 13, 2025
Reduced-Dose Edoxaban in Patients Aged ≥ 80 Years: A Single-Center Real-World AnalysisRuiqi Zhang, Jiali Du, Meilin LiuDrugs & Aging|September 11, 2025
Medication Non-adherence in Older Adults: Underlying Factors, Potential Interventions and OutcomesElstin Anbu Raj Stanly, Rajesh Vilakkathala, Johnson GeorgeDrugs & Aging|August 2, 2025
1-Month Versus 12-Month Dual Antiplatelet Therapy for Patients with Chronic Total Occlusion After Successful Percutaneous Coronary InterventionShuai Zhao, Boda Zhu, Yan Chen, et al.Drugs & Aging|May 7, 2013
The quality of quality measures: HEDIS® quality measures for medication management in the elderly and outcomes associated with new exposureMary Jo V Pugh, Zachary A Marcum, Laurel A Copeland, et al.Drugs & Aging|March 30, 2013
Efficacy and safety of insulin glargine compared to other interventions in younger and older adults: a pooled analysis of nine open-label, randomized controlled trials in patients with type 2 diabetesNaushira Pandya, Andres DiGenio, Ling Gao, et al.Drugs & Aging|March 5, 2013
Warfarin for prevention of thrombosis among long-term care residents with atrial fibrillation: evidence of continuing low use despite consideration of stroke and bleeding riskGregory Reardon, Winnie W Nelson, Aarti A Patel, et al.Drugs & Aging|March 12, 2013
Anticholinergic drug use, serum anticholinergic activity, and adverse drug events among older people: a population-based studyPasi Lampela, Piia Lavikainen, J Arturo Garcia-Horsman, et al.Drugs & Aging|February 2, 2013
Observational study of once-daily insulin detemir in people with type 2 diabetes aged 75 years or older: a sub-analysis of data from the Study of Once daily LeVEmir (SOLVE)Eddy Karnieli, Florian M M Baeres, Grzegorz Dzida, et al.Drugs & Aging|November 27, 2012
Antihypertensive efficacy and safety of olmesartan medoxomil and ramipril in elderly mild to moderate essential hypertensive patients with or without metabolic syndrome: a pooled post hoc analysis of two comparative trialsStefano Omboni, Ettore Malacco, Jean-Michel Mallion, et al.Pageof 279